Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lukas Hefermehl

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
BJU International|February 16, 2026
Patient-reported outcomes: active surveillance vs radical therapies in low-risk prostate cancerMulham Al-Nader, Claudia Kesch, Osama Mahmoud, et al.
European Urology Oncology|June 16, 2019
Consistent Biopsy Quality and Gleason Grading Within the Global Active Surveillance Global Action Plan 3 Initiative: A Prerequisite for Future StudiesTheo H van der Kwast, Jozien Helleman, Daan Nieboer, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
BJU International|February 16, 2026
Patient-reported outcomes: active surveillance vs radical therapies in low-risk prostate cancerMulham Al-Nader, Claudia Kesch, Osama Mahmoud, et al.
European Urology Oncology|June 16, 2019
Consistent Biopsy Quality and Gleason Grading Within the Global Active Surveillance Global Action Plan 3 Initiative: A Prerequisite for Future StudiesTheo H van der Kwast, Jozien Helleman, Daan Nieboer, et al.
Pageof 2